| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |